-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$15.67668.14% Upside
Rani Therapeutics Holdings, Inc. Frequently Asked Questions
-
What analysts cover Rani Therapeutics Holdings, Inc.?
Rani Therapeutics Holdings, Inc. has been rated by research analysts at Stifel Nicolaus, Canaccord Genuity, Wedbush in the past 90 days.